Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | PGR | P06401 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | SQLE | Q14534 | 2/20 | 0.50 |
| ▸ | FNTA | P49354 | 1/20 | 0.47 |
| ▸ | FNTB | P49356 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citral SCHEMBL3632554 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AALOX15MEN1CYP3A4 | |
| Citral SCHEMBL23073 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AALOX15MEN1CYP3A4 | |
| Citral SCHEMBL14977211 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AALOX15MEN1CYP3A4 | |
| Citral SCHEMBL19357313 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AALOX15MEN1CYP3A4 | |
| Citral SCHEMBL23074 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AALOX15MEN1CYP3A4 | |
| Citral SCHEMBL3643082 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AALOX15MEN1CYP3A4 | |
| Citral SCHEMBL1865532 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AALOX15MEN1CYP3A4 | |
| Citral SCHEMBL21491 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AALOX15MEN1CYP3A4 | |
| Citral SCHEMBL30931693 | 0.98 | ALDH1A1 (0.95) | ALDH1A1KMT2AALOX15MEN1CYP3A4 | |
| Citral SCHEMBL11328102 | 0.98 | ALDH1A1 (0.95) | ALDH1A1KMT2AALOX15MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118021774-A | Application of citral and beta-lactam antibiotics in preparation of medicines for treating diseases caused by enterobacteria | 青岛农业大学 | 2024-05-14 | — | — | CN | disclosed |
| US-20230211311-A1 | SYSTEMS AND METHODS FOR PROCESSING GASES | TRANSF MATERIALS LLC (US) | 2023-07-06 | — | — | US | disclosed |
| US-11633710-B2 | Systems and methods for processing gases | TRANSFORM MATERIALS LLC (US) | 2023-04-25 | — | — | US | disclosed |
| US-20210245133-A1 | SYSTEMS AND METHODS FOR PROCESSING GASES | CARBOGENESIS LLC | 2021-08-12 | — | — | US | disclosed |
| US-20200211703-A1 | LIQUID DISPENSING SYSTEM CREATING AND MAINTAINING A PERSONALIZED BUBBLE WITH A DEFINED RADIUS AND CONCENTRATION | SENSORY DESIGN & TECHNOLOGY LTD (GB) | 2020-07-02 | — | — | US | disclosed |
| EP-3365418-A2 | PARTICLES FOR MALODOR REDUCTION | The Procter and Gamble Company (US) | 2018-08-29 | — | — | EP | disclosed |
| EP-3197510-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | The Procter & Gamble Company (US) | 2017-08-02 | — | — | EP | disclosed |
| EP-3197426-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2017-08-02 | — | — | EP | disclosed |
| EP-3197422-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | The Procter & Gamble Company (US) | 2017-08-02 | — | — | EP | disclosed |
| EP-3197507-A1 | MALODOR REDUCTION COMPOSITIONS | The Procter and Gamble Company (US) | 2017-08-02 | — | — | EP | disclosed |
| US-20100104525-A1 | USE OF FRAGRANCE COMPOSITIONS FOR THE PREVENTION OF THE DEVELOPMENT OF INDOLE BASE MALODOURS FROM FECAL AND URINE BASED SOILS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-04-29 | — | — | US | disclosed |
| WO-2009117621-A1 | PEST CONTROL COMPOSITIONS AND METHODS | TYRATECH, INC. (US) | 2009-09-24 | — | — | WO | disclosed |
| CN-100438904-C | A Chinese medicinal composition for clearing away heat and toxic materials, and preventing and treating common cold, and its preparation method | POMIN HUANG (CN) | 2008-12-03 | — | — | CN | disclosed |
| US-20080032912-A1 | Use of fragrance compositions for the prevention of the development of indole base malodours from fecal and urine based soils | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-02-07 | — | — | US | disclosed |
| EP-1884251-A1 | Use of fragrance compositions for the prevention of the development of indole based malodours from faecal and urine based soils | Takasago International Corporation (JP) | 2008-02-06 | — | — | EP | disclosed |
| WO-2007038524-A2 | COCRYSTALLIZATION METHODS | SSCI, INC. (US) | 2007-04-05 | — | — | WO | disclosed |
| CN-1931356-A | A Chinese medicinal composition for clearing away heat and toxic materials, and preventing and treating common cold, and its preparation method | HUANG POMIN (CN) | 2007-03-21 | — | — | CN | disclosed |
| US-3997610-A | DISTILLATION, METAL BORATE | RHONE-POULENC S.A. (FR) | 1976-12-14 | — | — | US | disclosed |
| US-3971830-A | PALLADIUM CATALYST | RHODIA, INC. (US) | 1976-07-27 | — | — | US | disclosed |
| US-3971831-A | PALLADIUM CATALYST | RHONE-POULENC S.A. (FR) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230211311-A1 | SYSTEMS AND METHODS FOR PROCESSING GASES | F2, AHR, ACSS2 | ALDH1A1 4082/4885KMT2A 4023/4885ALOX15 193/4885 |
| US-20210245133-A1 | SYSTEMS AND METHODS FOR PROCESSING GASES | F2, AHR, ACSS2 | ALDH1A1 4082/4885KMT2A 4023/4885ALOX15 193/4885 |
| US-11633710-B2 | Systems and methods for processing gases | F2, AHR, ACSS2 | ALDH1A1 4082/4885KMT2A 4023/4885ALOX15 193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.